TRAIL (TNF-related apoptosis-inducing ligand), which plays a role in immune defense against viruses and cancer cell surveillance, along with its receptor Dr5, were also found to be upregulated at the mRNA level in cells treated with CLDVs. The gene discussed is TNFSF10; the disease is cancer.